Tharcisio Citrangulo Tortelli Jr

Dr. Tharcisio Citrangulo Tortelli Jr

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
GRGraziela Rosa Ravacci
Graziela Rosa Ravacci
MBMaria Mitzi Brentani
Maria Mitzi Brentani
TJTharcisio Citrangulo Tortelli Jr
Tharcisio Citrangulo Tortelli Jr
RTRaquel Suzana M.M. Torrinhas
Raquel Suzana M.M. Torrinhas
TSTatiana Saldanha
Tatiana Saldanha
DWDan Linetzky Waitzberg
Dan Linetzky Waitzberg

12 November 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GRGraziela Rosa Ravacci
Graziela Rosa Ravacci
MBMaria Mitzi Brentani
Maria Mitzi Brentani
TJTharcisio Citrangulo Tortelli Jr
Tharcisio Citrangulo Tortelli Jr
RTRaquel Suzana M. M. Torrinhas
Raquel Suzana M. M. Torrinhas
JSJéssica Reis Santos
Jéssica Reis Santos
DWDan Linetzky Waitzberg
Dan Linetzky Waitzberg
In breast cancer, lipid metabolic alterations have been recognized as potential oncogenic stimuli that may promote malignancy. To investigate whether the oncogenic nature of lipogenesis closely depends on the overexpression of HER2 protooncogene, the normal breast cell line, HB4a, was transfected with HER2 cDNA to obtain HER2-overexpressing HB4aC5.2 cells. Both cell lines were treated with trastuzumab and docosahexaenoic acid. HER2 overexpression was accompanied by an increase in the expression of lipogenic genes involved in uptake (CD36), transport (FABP4), and storage (DGAT) of exogenous fatty acids (FA), as well as increased activation of “de novo” FA synthesis (FASN). We further investigate whether this lipogenesis reprogramming might be regulated by mTOR/PPARγpathway. Inhibition of the mTORC1 pathway markers, p70S6 K1, SREBP1, and LIPIN1, as well as an increase in DEPTOR expression (the main inhibitor of the mTOR) was detected in HB4aC5.2. Based on these results, a PPARγselective antagonist, GW9662, was used to treat both cells lines, and the lipogenic genes remained overexpressed in the HB4aC5.2 but not HB4a cells. DHA treatment inhibited all lipogenic genes (except for FABP4) in both cell lines yet only induced death in the HB4aC5.2 cells, mainly when associated with trastuzumab. Neither trastuzumab nor GW9662 alone was able to induce cell death. In conclusion, oncogenic transformation of breast cells by HER2 overexpression may require a reprogramming of lipogenic genetic that is independent of mTORC1 pathway and PPARγactivity. This reprogramming was inhibited by DHA.

17 September 2021 in Neoplasia
Verified
Journal Article
Open access
AMAna Paula Morelli
Ana Paula Morelli
TJTharcisio Citrangulo Tortelli Jr
Tharcisio Citrangulo Tortelli Jr
MMMariana Camargo Silva Mancini
Mariana Camargo Silva Mancini
IPIsadora Carolina Betim Pavan
Isadora Carolina Betim Pavan
LSLuiz Guilherme Salvino Silva
Luiz Guilherme Salvino Silva
FSFernando Moreira Simabuco
Fernando Moreira Simabuco
• SILAC proteomics approach yielded important cisplatin resistance biomarkers in NSCLC. • Cisplatin resistance upregulated NER-based repair and downregulated mRNA splicing-related pathways. • STAT3 KO conferred epithelial morphology and sensitized to mTOR inhibition. • Cisplatin responsiveness is dependent on STAT3 and mTOR crosstalk in NSCLC cells. • Synergistically inhibition of STAT3 and mTOR is possibly a potential approach against NSCLC.

11 May 2017 in Oncotarget
Verified
Journal Article
Open access
TJTharcisio Citrangulo Tortelli Jr
Tharcisio Citrangulo Tortelli Jr
LGLyris Martins Franco de Godoy
Lyris Martins Franco de Godoy
GSGustavo Antonio de Souza
Gustavo Antonio de Souza
DBDiego Bonatto
Diego Bonatto
AOAndreia Hanada Otake
Andreia Hanada Otake
Roger ChammasRoger Chammas
Roger Chammas
Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death

6 October 2015 in FEBS Letters
Verified
Journal Article
Closed access
RSRenata de Freitas Saito
Renata de Freitas Saito
TJTharcisio Citrangulo Tortelli Jr
Tharcisio Citrangulo Tortelli Jr
MJMayara D'AUria Jacomassi
Mayara D'AUria Jacomassi
AOAndreia Hanada Otake
Andreia Hanada Otake
Roger ChammasRoger Chammas
Roger Chammas

14 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMauro César Cafundó Morais
Mauro César Cafundó Morais
ISIzabella Stuhl
Izabella Stuhl
ASAlan U. Sabino
Alan U. Sabino
WLWillian W. Lautenschlager
Willian W. Lautenschlager
AQAlexandre S. Queiroga
Alexandre S. Queiroga
Alexandre RamosAlexandre Ramos
Alexandre Ramos
Contact inhibition is a central feature orchestrating cell proliferation in culture experiments; its loss is associated with malignant transformation and tumorigenesis. We performed a co-culture experiment with human metastatic melanoma cell line (SKMEL- 147) and immortalized keratinocyte cells (HaCaT). After 8 days a spatial pattern was detected, characterized by the formation of clusters of melanoma cells surrounded by keratinocytes constraining their proliferation. In addition, we observed that the proportion of melanoma cells within the total population has increased. To explain our results we propose a spatial stochastic model (following a philosophy of the Widom-Rowlinson model from Statistical Physics and Molecular Chemistry) which considers cell proliferation, death, migration, and cell-to-cell interaction through contact inhibition. Our numerical simulations demonstrate that loss of contact inhibition is a sufficient mechanism, appropriate for an explanation of the increase in the proportion of tumor cells and generation of spatial patterns established in the conducted experiments.